AEDG comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-07-28. Where a claim depends on a specific study, the study is described rather than over-claimed.
Literature searches for this compound must account for several spelling variants. Indexing databases contain epitalon, epithalon, epithalone, and AEDG, and relevant records are scattered across Russian-language and English-language journals that do not consistently cross-cite. Early publications describe the parent extract as a mixture of many peptides, whereas later work addresses the single synthetic tetrapeptide. That shift in nomenclature complicates comparison between studies, because extract data and tetrapeptide data are sometimes cited interchangeably. A search strategy omitting the alternate spellings will return an incomplete set of references.
Reported biological findings come mainly from cell culture and rodent experiments. Those studies describe changes in telomerase catalytic subunit expression, melatonin rhythm amplitude, and antioxidant enzyme activity after peptide exposure. Human data are sparse and consist of small trials with limited blinding and inconsistent endpoints. The proposed mechanisms remain hypotheses rather than established facts, and there is no consensus on whether effects observed in animals carry over to people. Independent replication outside the original research groups is limited, which is a recognised gap in the published literature.
The parent extract epithalamin was characterised as a low-molecular-weight fraction of pineal tissue rather than a single defined chemical entity. Researchers fractionated it and tested successive fragments for activity, a screening approach typical of peptide discovery work in that era. Epitalon emerged from that process as one of the shorter sequences of interest. Because the original extract was never fully resolved into individual components, claims about which constituent drives a given effect rest on inference. This distinction matters when reading older reports that attribute extract observations to the tetrapeptide itself.
Dissolution is usually performed in water or a suitable aqueous buffer, and the resulting liquid is divided into single-use portions before freezing. Freeze-thaw cycling is a recognised source of loss for short peptides, since each cycle can encourage aggregation or adsorption onto container walls. Working solutions are generally kept cold and used within a short window, although published stability data specific to epitalon are thin. Containers should be marked with concentration and date, and solutions examined for cloudiness before use.
Identity is normally established by reversed-phase high-performance liquid chromatography combined with mass spectrometry, a pairing that separates components and confirms molecular mass at once. Purity is quoted as a percentage from the chromatogram, and figures above ninety-five percent are a frequent commercial specification. Amino acid analysis or sequencing supplies further confirmation when required. Because many short peptides behave similarly under chromatography, retention time alone does not establish sequence; the mass measurement is what separates one tetrapeptide from another, and certificates should report both.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic tetrapeptide | Four amino acid residues |
| Residue sequence | Ala-Glu-Asp-Gly | Abbreviated AEDG |
| Approximate mass | 390.35 Da | Monoisotopic, free base form |
| Parent preparation | Epithalamin extract | Derived from pineal tissue |
| Common spelling variants | Epithalon, epithalone, AEDG | Affects literature retrieval |
Interest in epitalon is usually discussed within the broader field of short peptide bioregulators, a category that includes other synthetic di-, tri-, and tetrapeptides studied by the same research group. These compounds share a common rationale: that small fragments of tissue-derived proteins can retain biological activity and can be produced reproducibly. The category as a whole remains outside mainstream pharmacological consensus, and epitalon specifically has a limited presence in independent, non-Russian research literature, which shapes how its evidence base is described.
Epitalon is a synthetic tetrapeptide with the amino acid sequence alanine-glutamate-aspartate-glycine, abbreviated Ala-Glu-Asp-Gly or AEDG. It was developed by the Russian researcher Vladimir Khavinson and colleagues during work on peptide bioregulators derived from the pineal gland. The compound is short enough to be produced by standard solid-phase peptide synthesis and is typically handled as a lyophilized white powder. Its small size distinguishes it from larger pineal peptides such as epithalamin, a complex extract from which the tetrapeptide was conceptually derived.
The four residues give epitalon a molecular formula of C14H22N4O9 and a molecular weight near 390.35 daltons. The presence of two acidic residues, glutamate and aspartate, makes the free peptide strongly acidic, while the alanine and glycine ends provide neutral, nonpolar character. This combination produces a molecule with substantial water solubility. Because there are no cysteine, methionine, or tryptophan residues, the peptide lacks the most common oxidation-sensitive side chains, which simplifies handling compared with many longer peptides.
Human data are limited to small studies, often without the randomization, blinding, or control groups expected in contemporary clinical research. Reported outcomes have included changes in melatonin levels, immune markers, and subjective measures, but sample sizes were generally too small to support firm conclusions. Some reviews treat the peptide as promising while noting methodological weaknesses; others question whether the observed effects are specific. The compound is frequently discussed in longevity-focused communities, where enthusiasm often outpaces the published evidence. Separating established findings from speculation is therefore important when reading summaries of this research.
Epitalon emerged from research conducted in Saint Petersburg by Vladimir Khavinson and colleagues, who studied short peptides as potential regulators of aging. The work built on epithalamin, a pineal gland extract reported to influence neuroendocrine function. Epitalon was designed as a synthetic counterpart with a defined sequence, allowing reproducible experiments that extracts could not support. Early publications described effects on melatonin rhythms and lifespan in animal models. These findings circulated mainly in Russian-language journals during the 1990s, which limited their visibility among English-speaking researchers.
Residue composition is the property that most cleanly separates verified material from mislabelled samples. Alanine, glutamate, aspartate and glycine appear in that order from the N-terminus, and the two acidic residues sit in the middle of the chain. Because the peptide is short, it can be produced by solid-phase synthesis and characterised by mass spectrometry without ambiguity. Any reported sample whose measured mass departs substantially from 390 daltons is a different compound or a degraded mixture rather than epitalon.
Epitalon is a synthetic tetrapeptide whose four residues are alanine, glutamate, aspartate and glycine, commonly abbreviated AEDG. Its molecular formula is C14H22N4O9 and its monoisotopic mass is near 390.35 daltons. The peptide carries two acidic side chains, so it is neutral to negatively charged in most aqueous buffers. Published reference summaries usually list it under both spellings, epitalon and epithalon, and treat the two names as the same material.
The compound is generally described as a synthetic analogue of a fragment isolated from a pineal gland extract. Researchers associated with the Saint Petersburg Institute of Bioregulation and Gerontology introduced it during the 1980s and 1990s while studying short peptides from animal tissue. The original extract, called epithalamin, is a heterogeneous mixture, whereas epitalon is a single defined sequence. That distinction matters because findings reported for the extract are not automatically findings about the pure tetrapeptide, and claims about broader biological effects remain a separate question from the chemical identity described here.
Lendemeriella aureopruinosa is a species of crustose lichen in the family Teloschistaceae. Found in the Russian Far East, it was formally described as a new species in 2021 by Ivan Frolov, Jan Vondrák, Ulf Arup, Liudmila Konoreva, and Sergey Chesnokov, Lidia Yakovchenko, and Evgeny Davydov. The type specimen was collected on the banks of River Bes-Yuryakh (Yllymakh, Republic of Sakha); here it was found growing on siliceous outcrops in a forest comprising largely birch, alder, and larch trees. The thallus of the lichen ranges in form from an inconspicuous grey film to a more well-developed crust or areoles. Its apothecia measure 0.3–0.6 mm in diameter and have a dark-orange to brick-red coloured disc. Secondary chemicals detected in the lichen (using high-performance liquid chromatography) include parietin, parietinic acid, emodin, teloschistin, and fallacinal. The specific epithet aureopruinosa refers to the bright gold-coloured pruina that is found on young apothecia.
In January 1996, Wenger guided the club to their first piece of silverware as Nagoya defeated Sanfrecce Hiroshima to win the Emperor's Cup. Two months later they triumphed in the Super Cup, beating Yokohama Marinos 2–0. The success bolstered Nagoya's status in Japanese football, as well as Wenger's reputation; he was somewhat startled by the praise and idolisation that came his way. Midway through the 1996 league season, Wenger's former club Strasbourg enquired about the possibility of him returning to manage them. He turned down the offer, as he had been approached by Arsenal. David Dein had remained in contact with Wenger after their first meeting, and frequently sent him video tapes of matches to garner his opinions; "He was my personal pundit," the vice-chairman recalled. The Arsenal board rebuffed Dein's suggestion to appoint Wenger as early as 1995, but concerns over George Graham's successor Bruce Rioch meant they were more open-minded about hiring him since his stint in Japan. Wenger managed Nagoya for the final time on 28 August 1996 and delivered a farewell speech, thanking the fans in Japanese. Assessing his time in Japan, biographer Jasper Rees felt Wenger had left a mixed legacy at the club, as the immediate success was followed by fluctuating league finishes; it was not until 2010 that Nagoya (under Stojković) won their first title.
There were also unpublicised transfers of technology, including the engagement of a US company, Continental Electronics, to design and build a new VLF communications station at Tirunelveli in Tamil Nadu, which was commissioned in the late 1980s.
=== Available forms === Arsenic trioxide (ATO) is available in both intravenous (IV) and oral formulations for clinical use. The IV form is widely approved and used as the standard for treating acute promyelocytic leukemia (APL), requiring daily infusions. Recent advances have led to the development of oral formulations, including liquid and solid (tablet/pill) preparations, designed to provide comparable bioavailability and efficacy to IV ATO. Specific formulations include:
Sources: en.wikipedia.org
The ILEA had fought off one attempt to abolish it in 1980. The abolition of the GLC, announced in 1983, led to another attempt to get rid of the ILEA, but the Inner London Boroughs were adjudged not ready to handle education services. The Conservative government was led by Margaret Thatcher, who had grown to dislike the ILEA as over-spending and over-bureaucratic while Education Secretary in the early 1970s, and would have liked to abolish it. Backbench Conservative MPs continued to oppose the continuation of the ILEA. The Education Reform Bill of Kenneth Baker proposed to allow Boroughs who wanted to opt out of the ILEA and become education authorities. However, the Government's hand was forced when an amendment was tabled in the House of Commons by Norman Tebbit and supported by Michael Heseltine to abolish the ILEA altogether. This unlikely alliance was particularly notable as Tebbit and Heseltine represented very different ideological wings of the Conservative Party. It was also the source of some local controversy at the time, as both members represented constituencies (Chingford and Henley respectively) outside the ILEA area. The Government announced on 4 February 1988 that it would accept the Tebbit/Heseltine amendment and abolish the ILEA in 1990 as part of the Education Reform Act 1988. Once the Bill was passed, the ILEA then complied with this decision in the interests of education. The Inner London boroughs then became education authorities, and remain so today.
Historically to protect people's privacy and correspondence, the post banned tampering with letters, and excluded post offices from responsibility for letters even if the contents were for something illegal. As the internet developed, the original Information Society Directive 1998 aimed for something similar, so that internet server providers or email hosts, for instance, protected privacy. After this the Electronic Commerce Directive 2000 also sought to ensure free movement for an "information society service", requiring member states to not restrict them unless it was to fulfill a public policy, prevent crime, fight incitement to hatred, protect individual dignity, protect health, or protect consumers or investors. Articles 12 to 14 further said that an ISS operating as a "mere conduit" for information, doing "caching" or "hosting" is 'not liable for information stored' if the 'provider does not have actual knowledge of illegal activity' and 'is not aware of facts or circumstances from which the illegal activity or information is apparent', but must act quickly to remove or disable access 'upon obtaining knowledge or awareness'. Article 15 states that member states should 'not impose a general obligation on providers... to monitor the information which they transmit or store' nor 'seek facts' on illegality. However the meaning of who was an "ISS" was not clearly defined in law, and has become a problem with social media that was not meant to be protected like private communication.
=== First measures === Right after taking office on 1 January 2023, Lula and his ministers took several measures to revert Bolsonaro policies and/or create policies announced during the election campaign and the transition of power. This processs, known as "desbolsonarização" (de-'Bolsonarization') or "revogaço" (mass repeal of decrees) by some ministers and party members included a series of federal decrees revoking the previous government's measures involving weapons, environment policies and top officials' data secrecy. Some of the decrees included temporarily suspending new authorizations for shooting clubs, revoking Bolsonaro government policies that allowed "artisan mining" in the Amazon rainforest area and indigenous lands (which were seen as an incentive to illegal miners). and the creation of the "Secretary of Digital Policies", which was to be established under the Secretary of Social Communications with the stated objective of "combatting the spread of disinformation, fake news and hate speech on the internet". On the same week, Environment and Climate Change Minister Marina Silva claimed that another "revogaço" was yet to come. Mostly related to the teto de gastos (debt ceiling) fiscal policy, which was seen as impractical by government officials. This policy was later replaced with another debt limit law following its approval in the Federal Congress.
Kumārajīva is known to have travelled repeatedly between Kucha and Kashmir around this time, and he may have been instrumental, among many others, in the transmission of this art. The structural prototype of the cave may be Kara Tepe in Bactria. The flat, well-delineated surfaces of the paintings remind of the Roman Opus sectile technique, which prospered circa 331–359 CE.
Cotadutide is an experimental drug for the treatment of type 2 diabetes mellitus. It lowers blood glucose levels by mimicking the human hormones glucagon-like peptide 1 and glucagon, which play a role in blood sugar regulation. The drug is a peptide that is injected under the skin. Cotadutide is in Phase II clinical trials as of February 2021. Cotadutide, a therapeutic agent, was undergoing Phase II clinical trials. This stage of trials typically involves evaluating the drug's effectiveness and further assessing its safety in a larger group of participants, compared to earlier phases. Glucagon (medication)
Sources: en.wikipedia.org
It is based on epithalamin, a peptide-rich preparation obtained from pineal gland tissue and studied in the former Soviet Union. Researchers later identified the tetrapeptide AEDG as a constituent fragment of that material. Modern supplies are produced by chemical synthesis rather than tissue extraction.
No. Epithalamin is a heterogeneous extract containing many peptides, while epitalon is a single synthesised tetrapeptide. Publications sometimes treat findings from the two as equivalent, which is a common source of confusion. Their compositions differ and they are not interchangeable in analytical terms.
Most published work uses cell cultures or rodents because those models are faster and less costly to run. The few human trials that have been reported are small, and several lack control groups or blinding. This restricts what can reasonably be concluded about effects in people.
Reversed-phase high-performance liquid chromatography is run alongside mass spectrometry. The chromatogram separates components and gives a purity figure, while the mass spectrum confirms that the measured molecular mass matches the expected sequence. Neither measurement on its own is treated as sufficient.